Myofascial Pain SyndromesNCT07689396
Predictors of Treatment Expectations in Myofascial Pain Syndrome
An observational study of Myofascial Pain Syndromes, run by KTO Karatay University at 1 site in Turkey (Türkiye).
Trial summary
This cross-sectional study aims to determine the predictors of treatment expectations in individuals with myofascial pain syndrome (MPS). MPS is one of the most common causes of musculoskeletal pain and is associated with reduced quality of life. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Myofascial Pain Syndromes
- How many people
- 97 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2026to 28 Aug 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults (18 years and older) diagnosed with myofascial pain syndrome who present to a private physiotherapy clinic in Konya, Turkiye and are scheduled to receive at least two weeks of physiotherapy.
Who may be able to join
- Age 18 years and older
- Diagnosis of myofascial pain syndrome
- Pain intensity of at least 3 on the Visual Analog Scale
- Scheduled to receive at least two weeks of physiotherapy
Who cannot join
- Diagnosed psychiatric disorder
- Chronic systemic disease
- Any barrier preventing communication
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Determining the Predictors of Treatment Expectations in Individuals With Myofascial Pain Syndrome: A Cross-Sectional Study
This cross-sectional study aims to determine the predictors of treatment expectations in individuals with myofascial pain syndrome (MPS). MPS is one of the most common causes of musculoskeletal pain and is associated with reduced quality of life. Patients' pre-treatment expectations are known to influence clinical outcomes, yet the factors that predict these expectations have not been established. Adults diagnosed with MPS who are scheduled to receive physiotherapy complete measures of treatment expectations, pain intensity and duration, health-related quality of life, and fatigue. Multiple regression analysis is used to examine the extent to which pain intensity, pain duration, quality of life, and fatigue predict treatment expectations.
Read the detailed description
Design and setting: Cross-sectional, descriptive study conducted at a private physiotherapy clinic in Konya, Turkiye, between April and August 2026.
Participants: Adults (18 years and older) with a diagnosis of MPS, a pain intensity of at least 3 on a visual analog scale, and scheduled to receive at least two weeks of physiotherapy. Individuals with a psychiatric diagnosis, a chronic systemic disease, or any barrier preventing communication are excluded.
Sample size: Based on an a priori power analysis (G*Power; effect size 0.15, power 0.80, alpha 0.05), a minimum of 85 participants is required.
Measures: A personal information form; the Treatment Expectation Questionnaire (TEX-Q), Turkish version, as the dependent variable; pain intensity and duration via a visual analog scale; health-related quality of life via the Short Form-36 (SF-36); and fatigue via the Brief Fatigue Inventory (BFI).
Analysis: Descriptive statistics, the Shapiro-Wilk test for normality, and multiple linear regression models (with 95% confidence intervals) to examine the associations between treatment expectations and pain intensity, pain duration, quality of life, and fatigue. Statistical significance is set at p<0.05.
- Conditions
- Myofascial Pain Syndromes
- Keywords
- pain, myofascial pain syndrome, treatment expectation, quality of life, fatigue
- Medical subject headings
- Myofascial Pain Syndromes, Pain, Fatigue
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Individuals with myofascial pain syndrome | Adults with a diagnosis of myofascial pain syndrome presenting to a private physiotherapy clinic and scheduled to receive at least two weeks of physiotherapy. Treatment expectations and candidate predictors are assessed once at enrollment. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Treatment expectations
Measured with the Treatment Expectation Questionnaire (TEX-Q), Turkish version. The total score of the first 15 items ranges from 0 to 150, with higher scores indicating greater treatment expectations.
Measured: At enrollment, before the physiotherapy program (single cross-sectional assessment)
Secondary outcomes (4)
Pain intensity
Assessed with a 10 cm Visual Analog Scale (VAS) for rest, activity, and night pain; 0 = no pain, 10 = unbearable pain.
Measured: At enrollment (single cross-sectional assessment)
Pain duration
Self-reported duration of pain complaints, recorded in weeks.
Measured: At enrollment (single cross-sectional assessment)
Health-related quality of life
Assessed with the Short Form-36 (SF-36). Subscale scores range from 0 to 100, with higher scores indicating better health status.
Measured: At enrollment (single cross-sectional assessment)
Fatigue
Assessed with the Brief Fatigue Inventory (BFI); higher scores indicate greater fatigue.
Measured: At enrollment (single cross-sectional assessment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jul 2026
- Study start1 Jul 2026
- Primary completion28 Aug 2026
- Study completion28 Aug 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Myofascial Pain SyndromesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 97 participants (actual)
Sponsor and investigators
- Lead sponsor
- KTO Karatay University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hasan Gerçek, KTO Karatay University
- Investigators
- Hasan Gercek, PT, PhD, Principal investigator, KTO Karatay University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07689396
- Sponsor's protocol ID
- KaratayUH19
- Status last verified
- Jul 2026
- First submitted
- 1 Jul 2026
- Last updated
- 31 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared.
Publications
Cakir F, Gercek H, Ozturk S, Kuru Colak T, Sari Z, Polat MG. The Treatment Expectation Questionnaire Tool: A Cross-Cultural Adaptation and Psychometric Evaluation in Turkey. Eval Health Prof. 2025 Sep;48(3):300-307. doi: 10.1177/01632787241268211. Epub 2024 Jul 26.
PubMed 39056487Alberts J, Lowe B, Glahn MA, Petrie K, Laferton J, Nestoriuc Y, Shedden-Mora M. Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open. 2020 Aug 20;10(8):e036169. doi: 10.1136/bmjopen-2019-036169.
PubMed 32819942
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determining the Predictors of Treatment Expectations in Individuals With Myofascial Pain Syndrome: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07689396
- Acronym / sponsor ID
- KaratayUH19
- Conditions
- Myofascial Pain Syndromes
- Keywords
- pain, myofascial pain syndrome, treatment expectation, quality of life, fatigue
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 97 participants (actual)
- Lead sponsor
- KTO Karatay UniversityUniversity, hospital or other
- Study start
- 1 Jul 2026 (actual)
- Primary completion
- 28 Aug 2026 (actual)
- Study completion
- 28 Aug 2026 (actual)
- First posted
- 8 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cross-sectional study aims to determine the predictors of treatment expectations in individuals with myofascial pain syndrome (MPS). MPS is one of the most common causes of musculoskeletal pain and is associated with reduced quality of life. Patients' pre-treatment expectations are known to influence clinical outcomes, yet the factors that predict these expectations have not been established. Adults diagnosed with MPS who are scheduled to receive physiotherapy complete measures of treatment expectations, pain intensity and duration, health-related quality of life, and fatigue. Multiple regression analysis is used to examine the extent to which pain intensity, pain duration, quality of life, and fatigue predict treatment expectations.
Detailed description
Design and setting: Cross-sectional, descriptive study conducted at a private physiotherapy clinic in Konya, Turkiye, between April and August 2026.
Participants: Adults (18 years and older) with a diagnosis of MPS, a pain intensity of at least 3 on a visual analog scale, and scheduled to receive at least two weeks of physiotherapy. Individuals with a psychiatric diagnosis, a chronic systemic disease, or any barrier preventing communication are excluded.
Sample size: Based on an a priori power analysis (G*Power; effect size 0.15, power 0.80, alpha 0.05), a minimum of 85 participants is required.
Measures: A personal information form; the Treatment Expectation Questionnaire (TEX-Q), Turkish version, as the dependent variable; pain intensity and duration via a visual analog scale; health-related quality of life via the Short Form-36 (SF-36); and fatigue via the Brief Fatigue Inventory (BFI).
Analysis: Descriptive statistics, the Shapiro-Wilk test for normality, and multiple linear regression models (with 95% confidence intervals) to examine the associations between treatment expectations and pain intensity, pain duration, quality of life, and fatigue. Statistical significance is set at p<0.05.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Individuals with myofascial pain syndrome | – | –Adults with a diagnosis of myofascial pain syndrome presenting to a private physiotherapy clinic and scheduled to receive at least two weeks of physiotherapy. Treatment expectations and candidate predictors are assessed once at enrollment. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults (18 years and older) diagnosed with myofascial pain syndrome who present to a private physiotherapy clinic in Konya, Turkiye and are scheduled to receive at least two weeks of physiotherapy.
Key inclusion criteria (4 listed)
- Age 18 years and older
- Diagnosis of myofascial pain syndrome
- Pain intensity of at least 3 on the Visual Analog Scale
- Scheduled to receive at least two weeks of physiotherapy
Key exclusion criteria (3 listed)
- Diagnosed psychiatric disorder
- Chronic systemic disease
- Any barrier preventing communication
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Treatment expectations
Time frame: At enrollment, before the physiotherapy program (single cross-sectional assessment)
Measured with the Treatment Expectation Questionnaire (TEX-Q), Turkish version. The total score of the first 15 items ranges from 0 to 150, with higher scores indicating greater treatment expectations.
4 secondary outcomes
Pain intensity
Time frame: At enrollment (single cross-sectional assessment)
Pain duration
Time frame: At enrollment (single cross-sectional assessment)
Health-related quality of life
Time frame: At enrollment (single cross-sectional assessment)
Fatigue
Time frame: At enrollment (single cross-sectional assessment)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2026.
- Background: PubMed 39056487Cakir F, Gercek H, Ozturk S, Kuru Colak T, Sari Z, Polat MG. The Treatment Expectation Questionnaire Tool: A Cross-Cultural Adaptation and Psychometric Evaluation in Turkey. Eval Health Prof. 2025 Sep;48(3):300-307. doi: 10.1177/01632787241268211. Epub 2024 Jul 26.
- Background: PubMed 32819942Alberts J, Lowe B, Glahn MA, Petrie K, Laferton J, Nestoriuc Y, Shedden-Mora M. Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews. BMJ Open. 2020 Aug 20;10(8):e036169. doi: 10.1136/bmjopen-2019-036169.
- Individual participant dataSharing planned: No. Individual participant data will not be shared.
Related trials for Myofascial Pain Syndromes
Not yet recruiting
Effects of IASTM, Deep Friction Massage, and Sham Instrument-Assisted Soft Tissue Mobilization on Electromyographical Activation, Pain and Function in Non-Specific Low Back Pain
Low Back Pain, Trigger Point Pain, Myofascial
Not yet recruiting
Comparing Dextrose Prolotherapy vs. Sodium Hyaluronic Acid Injections for Jaw Joint Internal Derangement
Temporomandibular Joint Internal Derangement, TMJ-ID
Active, not recruiting
Comparing Instrument-Assisted Soft Tissue Mobilization and Muscle Energy Technique for Myofascial Pain Syndrome in Women
Myofascial Pain Syndrome
Not yet recruitingObservational study
Agreement Between CSI and IASP Pain Classification in Chronic Cervical Myofascial Pain
Myofascial Pain Syndrome - Neck
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hasan Gercek, PT, PhD principal investigator
KTO Karatay University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Myofascial Pain Syndromes, run by KTO Karatay University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Treatment expectations (time frame: At enrollment, before the physiotherapy program (single cross-sectional assessment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07689396, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.